Literature DB >> 33138352

Quantifying the Selectivity of Protein-Protein and Small Molecule Interactions with Fluorinated Tandem Bromodomain Reader Proteins.

Prakriti Kalra1, Logan McGraw1, Jennifer R Kimbrough1, Anil K Pandey1, Jonathan Solberg2, Huarui Cui1, Anand Divakaran3, Kristen John2, Jon E Hawkinson2,3, William C K Pomerantz1,3.   

Abstract

Multidomain bromodomain-containing proteins regulate gene expression via chromatin binding, interactions with the transcriptional machinery, and by recruiting enzymatic activity. Selective inhibition of members of the bromodomain and extra-terminal (BET) family is important to understand their role in disease and gene regulation, although due to the similar binding sites of BET bromodomains, selective inhibitor discovery has been challenging. To support the bromodomain inhibitor discovery process, here we report the first application of protein-observed fluorine (PrOF) NMR to the tandem bromodomains of BRD4 and BRDT to quantify the selectivity of their interactions with acetylated histones as well as small molecules. We further determine the selectivity profile of a new class of ligands, 1,4-acylthiazepanes, and find them to have ≥3-10-fold selectivity for the C-terminal bromodomain of both BRD4 and BRDT. Given the speed and lower protein concentration required over traditional protein-observed NMR methods, we envision that these fluorinated tandem proteins may find use in fragment screening and evaluating nucleosome and transcription factor interactions.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33138352      PMCID: PMC8185897          DOI: 10.1021/acschembio.0c00720

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  57 in total

1.  Structure and function of a human TAFII250 double bromodomain module.

Authors:  R H Jacobson; A G Ladurner; D S King; R Tjian
Journal:  Science       Date:  2000-05-26       Impact factor: 47.728

2.  The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis.

Authors:  Anup Dey; Farideh Chitsaz; Asim Abbasi; Tom Misteli; Keiko Ozato
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-02       Impact factor: 11.205

Review 3.  Epigenetic protein families: a new frontier for drug discovery.

Authors:  Cheryl H Arrowsmith; Chas Bountra; Paul V Fish; Kevin Lee; Matthieu Schapira
Journal:  Nat Rev Drug Discov       Date:  2012-04-13       Impact factor: 84.694

Review 4.  Current applications of 19F NMR to studies of protein structure and dynamics.

Authors:  Julianne L Kitevski-LeBlanc; R Scott Prosser
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2011-07-13       Impact factor: 9.795

5.  Brd4 coactivates transcriptional activation of NF-kappaB via specific binding to acetylated RelA.

Authors:  Bo Huang; Xiao-Dong Yang; Ming-Ming Zhou; Keiko Ozato; Lin-Feng Chen
Journal:  Mol Cell Biol       Date:  2008-12-22       Impact factor: 4.272

6.  Evaluating the Advantages of Using 3D-Enriched Fragments for Targeting BET Bromodomains.

Authors:  Jorden A Johnson; Christos A Nicolaou; Steven E Kirberger; Anil K Pandey; Haitao Hu; William C K Pomerantz
Journal:  ACS Med Chem Lett       Date:  2019-11-22       Impact factor: 4.345

7.  Brd4 maintains constitutively active NF-κB in cancer cells by binding to acetylated RelA.

Authors:  Z Zou; B Huang; X Wu; H Zhang; J Qi; J Bradner; S Nair; L-F Chen
Journal:  Oncogene       Date:  2013-05-20       Impact factor: 9.867

8.  Molecular Basis for the N-Terminal Bromodomain-and-Extra-Terminal-Family Selectivity of a Dual Kinase-Bromodomain Inhibitor.

Authors:  Anand Divakaran; Siva K Talluri; Alex M Ayoub; Neeraj K Mishra; Huarui Cui; John C Widen; Norbert Berndt; Jin-Yi Zhu; Angela S Carlson; Joseph J Topczewski; Ernst K Schonbrunn; Daniel A Harki; William C K Pomerantz
Journal:  J Med Chem       Date:  2018-10-16       Impact factor: 7.446

9.  Design, Synthesis, and Characterization of a Fluorescence Polarization Pan-BET Bromodomain Probe.

Authors:  Carolyn N Paulson; Xianghong Guan; Alex M Ayoub; Alice Chan; Rezaul M Karim; William C K Pomerantz; Ernst Schönbrunn; Gunda I Georg; Jon E Hawkinson
Journal:  ACS Med Chem Lett       Date:  2018-10-31       Impact factor: 4.345

10.  Covalent-Fragment Screening of BRD4 Identifies a Ligandable Site Orthogonal to the Acetyl-Lysine Binding Sites.

Authors:  Michael D Olp; Daniel J Sprague; Christopher J Goetz; Stefan G Kathman; Sarah L Wynia-Smith; Shifali Shishodia; Steven B Summers; Ziyang Xu; Alexander V Statsyuk; Brian C Smith
Journal:  ACS Chem Biol       Date:  2020-03-23       Impact factor: 5.100

View more
  2 in total

1.  Dihydropyridine Lactam Analogs Targeting BET Bromodomains.

Authors:  Jiewei Jiang; Logan H Sigua; Alice Chan; Prakriti Kalra; William C K Pomerantz; Ernst Schönbrunn; Jun Qi; Gunda I Georg
Journal:  ChemMedChem       Date:  2021-12-21       Impact factor: 3.466

Review 2.  Opportunity knocks for uncovering the new function of an understudied nucleosome remodeling complex member, the bromodomain PHD finger transcription factor, BPTF.

Authors:  Huda Zahid; Noelle M Olson; William C K Pomerantz
Journal:  Curr Opin Chem Biol       Date:  2021-03-08       Impact factor: 8.972

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.